Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Hyperglycemia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma 2Leukemia 2Leukemia, Myeloid, Acute 1Insulin Resistance 1Hyperphagia 1Diabetes Mellitus, Type 2 1Congenital Abnormalities 1Burkitt Lymphoma 1

Interventions

fludarabine phosphate 73Peripheral Blood Stem Cell Transplantation 63Cyclophosphamide 59Busulfan 51Tacrolimus 46Mycophenolic Acid 46Cytarabine 44Whole-Body Irradiation 41Cyclosporine 37Methotrexate 34Antilymphocyte Serum 33Filgrastim 30Etoposide 29Radiotherapy 22Melphalan 21Flow Cytometry 21Cord Blood Stem Cell Transplantation 17Mitoxantrone 14Methylprednisolone 14Transplantation 13Granulocyte Colony-Stimulating Factor 12Idarubicin 11Clofarabine 11sargramostim 10aldesleukin 10Thiotepa 9Polymerase Chain Reaction 9Alemtuzumab 9merphos 8Therapeutics 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Congenital Abnormalities × Insulin Glargine × Clear all
NCT00943709 2013-08-30

Intensive Glycemic Control on Infectious Morbidity In Patients With Acute Leukemia

Rutgers, The State University of New Jersey

Phase 3 Withdrawn
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Hyperglycemia, Leukemia, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡